Comparison of glycemic and lipid response to pioglitazone treatment in Mexican-Americans and non-Hispanic Caucasians with type 2 diabetes.
King
Allen B
AB
Armstrong
Dana U
DU
Chinnapongse
Sithiphol
S
D000328:Adult; D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000208:ethnology; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D008055:Lipids / Q000097:blood*; D017058:Mexican Americans; D008875:Middle Aged; D000077205:Pioglitazone; D012189:Retrospective Studies; D013844:Thiazoles / Q000008:administration & dosage*; D045162:Thiazolidinediones; D044465:White People
D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D008055:Lipids; D000077205:Pioglitazone; D013844:Thiazoles; D045162:Thiazolidinediones